Latest Ai Platforms News

Caprice Resources has reported significant progress in its December 2025 quarter, delivering high-grade gold assay results from its Island Gold Project and expanding its landholding in the Murchison Goldfields through the strategic acquisition of the Comet Gold Project.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

XPON Technologies Group delivered a robust Q1 FY26 with an 8.3% revenue increase and positive operating cash flow, underpinned by successful Alpha Digital integration and strong recurring revenue.

FlexiRoam has reported its second consecutive quarter of positive operating cash flow and returned to a positive net current asset position for the first time in over eight years, underpinned by record underlying EBITDA and strategic AI partnerships.

RocketBoots Limited has secured a transformative $9.1 million annual contract with a major multinational retailer, alongside a $7 million capital raise to accelerate its international growth strategy.

Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.

Energy Action Limited reported positive operating cash flow for Q2 FY26 and secured a deferral on key loan repayments while investing in its AI-powered platform and appointing new board members.

ikeGPS Group has reported a robust 35% increase in its platform subscription revenue exit run rate for the nine months to December 2025, reaffirming its FY26 growth guidance amid strong market demand and new AI-driven product launches.

Northern Minerals has identified a promising new heavy rare earths target, the Vulcan prospect, through extensive drilling and soil sampling at its Browns Range project in Western Australia. This discovery, alongside advances in geological modelling and AI-driven exploration, signals a strategic step forward in the company’s rare earths ambitions.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.